Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty
- PMID: 27777294
- PMCID: PMC5111875
- DOI: 10.1161/CIRCULATIONAHA.115.021014
Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty
Abstract
Background: In ischemic mitral regurgitation (IMR), ring annuloplasty is associated with a significant rate of recurrent MR. Ring size is based on intertrigonal distance without consideration of left ventricular (LV) size. However, LV size is an important determinant of mitral valve (MV) leaflet tethering before and after repair. We aimed to determine whether LV-MV ring mismatch (mismatch of LV size relative to ring size) is associated with recurrent MR in patients with IMR after restrictive ring annuloplasty.
Methods: Patients with moderate or severe IMR from the 2 Cardiothoracic Surgical Trials Network IMR trials who received MV repair were examined at 1 year after surgery. Baseline LV size was assessed by LV end-diastolic dimension and LV end-systolic dimension (LVESd). LV-MV ring mismatch was calculated as the ratio of LV to ring size (LV end-diastolic dimension/ring size and LVESd/ring size).
Results: At 1 year after ring annuloplasty, 45 of 214 patients with MV repair (21%) had moderate or greater MR. In univariable logistic regression analysis, larger LVESd (P=0.02) and LVESd/ring size (P=0.007) were associated with recurrent MR. In multivariable models adjusted for age, sex, baseline LV ejection fraction, and severe IMR, only LVESd/ring size (odd ratio per 0.5 increase, 2.20; 95% confidence interval, 1.05-4.62; P=0.038) remained significantly associated with 1-year MR recurrence.
Conclusions: LV-MV ring size mismatch is associated with increased risk of MR recurrence. This finding may be helpful in guiding choice of ring size to prevent recurrent MR in patients undergoing MV repair and in identifying patients who may benefit from MV repair with additional subvalvular intervention or MV replacement rather than repair alone.
Clinical trial registration: URL:http://clinicaltrials.gov. Unique identifiers: NCT00806988 and NCT00807040.
Keywords: ischemic heart disease; mitral regurgitation; mitral valve; mitral valve annuloplasty.
© 2016 American Heart Association, Inc.
Conflict of interest statement
and Disclosures: GA has served as consultant for Abbott Vascular, Edwards and Atricure. DA has served as consultant for Celldon Corp. PG has served as consultant for Abbott Vascular, Tendyne and Bracco Diagnostics; has received research funding from Abbott Vascular, Edwards Lifesciences, Medtronic, Boston Scientific and Tendyne; has Echo Core Laboratory contracts from Valtech Cardio, Tendyne. MM sits at the Steering Committees of trials for Edwards Lifesciences and Abbott Vascular (uncompensated); has received travel expenses paid for committee meetings. The other authors have reported no relationships relevant to the contents of this paper to disclose.
Figures
Comment in
-
Left ventricle-mitral valve ring size mismatch: understanding the limitations of mitral valve repair for ischemic mitral regurgitation.Ann Transl Med. 2017 Jan;5(1):19. doi: 10.21037/atm.2016.12.65. Ann Transl Med. 2017. PMID: 28164104 Free PMC article. No abstract available.
-
Letter by Pocar Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".Circulation. 2017 Mar 21;135(12):e783-e784. doi: 10.1161/CIRCULATIONAHA.116.026127. Circulation. 2017. PMID: 28320811 No abstract available.
-
Response by Capoulade et al to Letter Regarding Article, "Impact of Left Ventricular to Mitral Valve Ring Mismatch on Recurrent Ischemic Mitral Regurgitation After Ring Annuloplasty".Circulation. 2017 Mar 21;135(12):e785-e786. doi: 10.1161/CIRCULATIONAHA.117.026957. Circulation. 2017. PMID: 28320812 Free PMC article. No abstract available.
References
-
- Bursi F, Enriquez-Sarano M, Nkomo VT, Jacobsen SJ, Weston SA, Meverden RA, Roger VL. Heart failure and death after myocardial infarction in the community: the emerging role of mitral regurgitation. Circulation. 2005;111:295–301. - PubMed
-
- Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation. Long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759–1764. - PubMed
-
- Lamas GA, Mitchell GF, Flaker GC, Smith SC, Jr, Gersh BJ, Basta L, Moye L, Braunwald E, Pfeffer MA. Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation. 1997;96:827–833. - PubMed
-
- Koelling TM, Aaronson KD, Cody RJ, Bach DS, Armstrong WF. Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction. Am Heart J. 2002;144:524–529. - PubMed
-
- Flynn M, Curtin R, Nowicki ER, Rajeswaran J, Flamm SD, Blackstone EH, Mihaljevic T. Regional wall motion abnormalities and scarring in severe functional ischemic mitral regurgitation: A pilot cardiovascular magnetic resonance imaging study. J Thorac Cardiovasc Surg. 2009;137:1063–1070. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
